WHO ICTRP trial

Comparing the satiety and blood glucose effects of formulated beverages in…

ACTRN12615001118594 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12615001118594
Public title Comparing the satiety and blood glucose effects of formulated beverages in adults
Scientific title Satiety and blood glucose measurement trial to determine the effects of formulated beverages with red grape skin extract in healthy adults
Primary sponsor The New Zealand Institute for Plant & Food Research Ltd
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries New Zealand
Conditions Appetite control;Blood glucose response; Appetite control Blood glucose response;Diet and Nutrition - Obesity
Interventions The potential satiety ingredient, Oxifend Red Grape Extract (RGE) is sourced from New Zealand Extracts Ltd. The aim of this study is to compare 3 formulated beverages, without RGE (control), with low dose RGE (1.25g in 250mL serve) and with…
Registration date Oct 23, 2015
Target size 30
Secondary IDs Nil known
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations